DilenyTech is a developer of a breast cancer risk assessment tool designed to estimate women's risk to develop invasive breast cancer and lifetime risk.
⏰ Founding Date:
🏙 Country:Egypt
🏬 Industry:Health
🗄 Stage Type:Series A
💰 Last Funding Amount:$160,000
👨🏻 Last Funding Investors:Information Technology Academia Collaboration (ITAC) program